Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_022912.2(REEP1):c.*43G>T | 65055 | REEP1 | Pathogenic;Uncertain significance | 377637314 | RCV000001938; RCV000200803; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011; MedGen:CN169374 | 2 | 86444180 | 86444180 | NM_022912.2:c.*43G>T | | | OMIM Allelic Variant:609139.0003 | CN169374 not specified; C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_022912.2(REEP1):c.595+1G>A | 65055 | REEP1 | Pathogenic | 869312880 | RCV000210477; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86459747 | 86459747 | NM_022912.2:c.595+1G>A | | NC_000002.11:g.86459747C>T | - | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_001164730.1(REEP1):c.533delC (p.Pro178Hisfs) | 65055 | REEP1 | Pathogenic | 387906263 | RCV000001936; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86459831 | 86459831 | NM_001164730.1:c.533delC | NP_001158202.1:p.Pro178Hisfs | NC_000002.11:g.86459831delG | OMIM Allelic Variant:609139.0001 | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_022912.2(REEP1):c.486C>T (p.Asp162=) | 65055 | REEP1 | Benign | 139806812 | RCV000203687; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86459857 | 86459857 | NM_022912.2:c.486C>T | NP_075063.1:p.Asp162= | NC_000002.11:g.86459857G>A | - | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_022912.2(REEP1):c.424G>C (p.Gly142Arg) | 65055 | REEP1 | Uncertain significance | 864622642 | RCV000204692; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86459919 | 86459919 | NM_022912.2:c.424G>C | NP_075063.1:p.Gly142Arg | NC_000002.11:g.86459919C>G | - | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_022912.2(REEP1):c.415A>T (p.Lys139Ter) | 65055 | REEP1 | Pathogenic | 786204081 | RCV000167976; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86479082 | 86479082 | NM_022912.2:c.415A>T | NP_075063.1:p.Lys139Ter | NC_000002.11:g.86479082T>A | - | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_022912.2(REEP1):c.396G>A (p.Ala132=) | 65055 | REEP1 | Uncertain significance | 377712421 | RCV000197628; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86479101 | 86479101 | NM_022912.2:c.396G>A | NP_075063.1:p.Ala132= | NC_000002.11:g.86479101C>T | - | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_001164730.1(REEP1):c.358C>T (p.Arg120Ter) | 65055 | REEP1 | Pathogenic | 121918263 | RCV000001940; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86479160 | 86479160 | NM_001164730.1:c.358C>T | NP_001158202.1:p.Arg120Ter | NC_000002.11:g.86479160G>A | OMIM Allelic Variant:609139.0005 | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_022912.2(REEP1):c.183-2A>G | 65055 | REEP1 | Pathogenic | 387906264 | RCV000001937; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86481939 | 86481939 | NM_022912.2:c.183-2A>G | | NC_000002.11:g.86481939T>C | OMIM Allelic Variant:609139.0002 | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |
NM_001164730.1(REEP1):c.80C>A (p.Ala27Glu) | 65055 | REEP1 | Pathogenic | 121918262 | RCV000001939; | N | MedGen:C1853247,OMIM:610250,ORPHA:101011 | 2 | 86509339 | 86509339 | NM_001164730.1:c.80C>A | NP_001158202.1:p.Ala27Glu | NC_000002.11:g.86509339G>T | OMIM Allelic Variant:609139.0004 | C1853247 610250 Spastic paraplegia 31, autosomal dominant | | |